JP2008531637A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531637A5
JP2008531637A5 JP2007557447A JP2007557447A JP2008531637A5 JP 2008531637 A5 JP2008531637 A5 JP 2008531637A5 JP 2007557447 A JP2007557447 A JP 2007557447A JP 2007557447 A JP2007557447 A JP 2007557447A JP 2008531637 A5 JP2008531637 A5 JP 2008531637A5
Authority
JP
Japan
Prior art keywords
vzv
use according
antigen
adjuvant
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007557447A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531637A (ja
JP5420842B2 (ja
Filing date
Publication date
Priority claimed from GBGB0504436.7A external-priority patent/GB0504436D0/en
Application filed filed Critical
Publication of JP2008531637A publication Critical patent/JP2008531637A/ja
Publication of JP2008531637A5 publication Critical patent/JP2008531637A5/ja
Application granted granted Critical
Publication of JP5420842B2 publication Critical patent/JP5420842B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007557447A 2005-03-03 2006-03-01 水疱−帯状疱疹ウイルスワクチン Expired - Lifetime JP5420842B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0504436.7 2005-03-03
GBGB0504436.7A GB0504436D0 (en) 2005-03-03 2005-03-03 Vaccine
PCT/EP2006/002070 WO2006094756A2 (en) 2005-03-03 2006-03-01 Varicella zoster virus vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013080447A Division JP5840167B2 (ja) 2005-03-03 2013-04-08 水疱−帯状疱疹ウイルスワクチン

Publications (3)

Publication Number Publication Date
JP2008531637A JP2008531637A (ja) 2008-08-14
JP2008531637A5 true JP2008531637A5 (enExample) 2009-03-12
JP5420842B2 JP5420842B2 (ja) 2014-02-19

Family

ID=34430592

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007557447A Expired - Lifetime JP5420842B2 (ja) 2005-03-03 2006-03-01 水疱−帯状疱疹ウイルスワクチン
JP2013080447A Expired - Lifetime JP5840167B2 (ja) 2005-03-03 2013-04-08 水疱−帯状疱疹ウイルスワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013080447A Expired - Lifetime JP5840167B2 (ja) 2005-03-03 2013-04-08 水疱−帯状疱疹ウイルスワクチン

Country Status (36)

Country Link
US (3) US20080171079A1 (enExample)
EP (4) EP2281830B1 (enExample)
JP (2) JP5420842B2 (enExample)
KR (2) KR101357204B1 (enExample)
CN (2) CN101189254B (enExample)
AR (2) AR052498A1 (enExample)
AU (1) AU2006222225B2 (enExample)
BE (1) BE2018C035I2 (enExample)
BR (1) BRPI0607840B1 (enExample)
CA (2) CA2600905C (enExample)
CY (5) CY1116108T1 (enExample)
DK (4) DK2281830T3 (enExample)
EA (1) EA011884B1 (enExample)
ES (4) ES2618037T3 (enExample)
FR (1) FR18C1040I2 (enExample)
GB (1) GB0504436D0 (enExample)
HR (4) HRP20150142T1 (enExample)
HU (4) HUE032544T2 (enExample)
IL (1) IL185442A (enExample)
LT (4) LT2281831T (enExample)
LU (1) LUC00087I2 (enExample)
MA (1) MA29714B1 (enExample)
MX (2) MX346865B (enExample)
MY (1) MY148464A (enExample)
NL (1) NL300951I2 (enExample)
NO (2) NO341841B1 (enExample)
NZ (1) NZ561075A (enExample)
PE (2) PE20100658A1 (enExample)
PL (4) PL2281830T3 (enExample)
PT (4) PT2281831T (enExample)
SI (4) SI2281830T1 (enExample)
TR (2) TR201809397T4 (enExample)
TW (1) TWI403517B (enExample)
UA (1) UA94900C2 (enExample)
WO (1) WO2006094756A2 (enExample)
ZA (1) ZA200707144B (enExample)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US20100330122A1 (en) * 2007-07-19 2010-12-30 Gale Smith VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS
FR2952825B1 (fr) 2009-11-24 2012-05-25 Goaster Jacqueline Le Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2
CN103153284B (zh) 2010-07-06 2015-11-25 诺华股份有限公司 含有其pKa值有利于RNA递送的脂质的脂质体
US10487332B2 (en) 2010-07-06 2019-11-26 Glaxosmithkline Biologicals Sa Immunisation of large mammals with low doses of RNA
PT3243526T (pt) 2010-07-06 2020-03-04 Glaxosmithkline Biologicals Sa Distribuição de arn para despoletar múltiplas vias imunitárias
UA112970C2 (uk) * 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
JP5911870B2 (ja) 2010-08-31 2016-04-27 ノバルティス アーゲー 免疫原をコードするｒｎａの送達のためのｐｅｇ化リポソーム
KR102266691B1 (ko) 2010-10-11 2021-06-23 노파르티스 아게 항원 전달 플랫폼
JP2014522842A (ja) 2011-07-06 2014-09-08 ノバルティス アーゲー 免疫原性組み合わせ組成物およびその使用
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
CN105530953A (zh) * 2013-10-03 2016-04-27 日东电工株式会社 注射疫苗组合物
JP6499420B2 (ja) * 2014-11-13 2019-04-10 公益財団法人ヒューマンサイエンス振興財団 ワクチン及び感染防御キット
BE1022523B1 (fr) * 2014-12-18 2016-05-20 Glaxosmithkline Biologicals Sa Vaccination
CA2970840A1 (en) * 2014-12-18 2016-06-23 Glaxosmithkline Biologicals S.A. Vaccine composition comprising truncated varicella zoster virus glycoprotein e antigen
DE20164728T1 (de) 2015-10-22 2021-09-30 Modernatx, Inc. Impfstoffe gegen atemwegsvirus
SG11201803360UA (en) * 2015-10-22 2018-05-30 Modernatx Inc Nucleic acid vaccines for varicella zoster virus (vzv)
IL286493B (en) 2015-11-06 2022-07-01 Memorial Sloan Kettering Cancer Center Triterpene saponin analogues, methods of producing same, compositions comprising same and uses thereof
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
US10874734B2 (en) 2016-11-25 2020-12-29 Mogam Institute For Biomedical Research Varicella zoster virus vaccine
WO2018097642A1 (ko) * 2016-11-25 2018-05-31 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
CN107022559A (zh) * 2016-12-08 2017-08-08 长春祈健生物制品有限公司 一种水痘‑带状疱疹病毒糖蛋白e胞外区蛋白的制备方法
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
MX2019007288A (es) * 2016-12-26 2019-10-02 Mogam Inst Biomedical Res Composicion de vacuna para herpes zoster.
CN108727503A (zh) * 2017-04-18 2018-11-02 武汉博沃生物科技有限公司 VZV重组gE-鞭毛素融合蛋白及其制备方法和应用
CN110582282A (zh) * 2017-04-25 2019-12-17 佐剂技术公司 三萜皂苷类似物
US20200164065A1 (en) * 2017-04-25 2020-05-28 Adjuvance Technologies, Inc. Triterpene saponin analogues
US20210187098A1 (en) 2017-04-28 2021-06-24 Glaxosmithkline Biologicals Sa Vaccination
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
GB2600652B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel compositions
JP2020536946A (ja) 2017-10-16 2020-12-17 アジュバンス・テクノロジーズ・インコーポレーテッド トリテルペンサポニン類似物
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
CN108315344A (zh) * 2018-02-14 2018-07-24 武汉博沃生物科技有限公司 Vzv糖蛋白e基因表达载体及其重组酵母菌株与应用
KR20190121956A (ko) 2018-04-19 2019-10-29 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
KR102337922B1 (ko) 2018-04-19 2021-12-09 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
CN112189017B (zh) 2018-05-23 2024-12-27 财团法人牧岩生命科学研究所 水痘带状疱疹病毒的抗原变体及其用途
BR112021000965A2 (pt) 2018-08-07 2021-04-27 Glaxosmithkline Biologicals S.A. processos e vacinas
CN108992667A (zh) * 2018-08-09 2018-12-14 安徽智飞龙科马生物制药有限公司 一种带状疱疹疫苗及其制备方法、应用
KR102270048B1 (ko) * 2020-07-10 2021-06-28 주식회사 녹십자 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법
CA3114658A1 (en) * 2018-09-27 2020-04-02 Bravovax Co., Ltd Immune composition, preparation method therefor and use thereof
EP3886901A1 (en) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
CN109602901B (zh) * 2019-01-08 2022-05-27 成都迈科康生物科技有限公司 一种带状疱疹病毒疫苗及其制备方法和应用
MA55321A (fr) 2019-03-15 2022-01-19 Modernatx Inc Vaccins à base d'arn contre le vih
WO2020245207A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification
CN112138153B (zh) * 2019-06-28 2022-08-23 怡道生物科技(苏州)有限公司 一种重组带状疱疹疫苗组合物及其用途
CN112142828B (zh) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 一种gE基因及表达该基因的载体
AU2020379738A1 (en) 2019-11-05 2022-04-14 Adjuvance Technologies, Inc. Varicella zoster
AU2020403296B2 (en) 2019-12-13 2025-03-06 Grand Theravac Life Science (Nanjing) Co., Ltd. Immunostimulatory composition and use thereof
WO2021172971A1 (ko) * 2020-02-28 2021-09-02 (주)셀트리온 수두 대상포진 바이러스 융합 단백질 및 이를 포함하는 면역원성 조성물
US12569553B2 (en) 2020-03-09 2026-03-10 Dynavax Technologies Corporation Shingles vaccines comprising a TLR9 agonist
AU2021321944A1 (en) 2020-08-07 2023-04-06 Access To Advanced Health Institute Purified saponins and chromatographic process for purification of same
US12527859B2 (en) 2020-09-11 2026-01-20 Eubiologics Co., Ltd. Vaccine composition for chickenpox or Varicella Zoster and method of using same
RU2750818C1 (ru) * 2020-11-19 2021-07-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова Вирусный штамм для получения аттенуированной живой культуральной вакцины для профилактики и лечения опоясывающего герпеса для взрослого населения
WO2023056912A1 (en) * 2021-10-08 2023-04-13 Suzhou Abogen Biosciences Co., Ltd. Nucleic acid vaccines for vzv
WO2023064612A2 (en) 2021-10-15 2023-04-20 BioNTech SE Pharmaceutical compositions for delivery of viral antigens and related methods
MX2024006407A (es) 2021-11-24 2024-08-19 Flagship Pioneering Innovations Vi Llc Composiciones de inmunogenos del virus varicela-zoster y sus usos.
CN116327912A (zh) * 2021-12-23 2023-06-27 上海泽润生物科技有限公司 带状疱疹疫苗组合物
CN116350770B (zh) * 2021-12-28 2024-07-12 成都迈科康生物科技有限公司 一种带状疱疹疫苗制剂及其制备方法
WO2023124116A1 (zh) * 2021-12-28 2023-07-06 成都迈科康生物科技有限公司 一种疫苗佐剂、其制备方法及应用
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production
CN116655748B (zh) * 2023-02-28 2024-07-26 易慧生物技术(上海)有限公司 一种截短型水痘-带状疱疹病毒gE蛋白及其应用
CN118240844B (zh) * 2024-05-27 2024-12-13 北京悦康科创医药科技股份有限公司 带状疱疹mRNA疫苗及其制备方法和应用
WO2026006687A1 (en) * 2024-06-28 2026-01-02 Orbital Therapeutics, Inc. Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus
CN120081913B (zh) * 2025-05-08 2025-08-12 江苏华诺泰生物医药科技有限公司 一种重组带状疱疹病毒原液的纯化方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (enExample) 1974-03-12 1978-11-01
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4769239A (en) 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
ATE119939T1 (de) 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.
EP0468520A3 (en) 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
JP3723231B2 (ja) 1991-12-23 2005-12-07 ディミナコ アクチェンゲゼルシャフト アジュバント
DE69313134T2 (de) * 1992-06-25 1998-02-26 Smithkline Beecham Biolog Adjuvantien enthaltende impfstoffzusammensetzung
PT651789E (pt) 1992-07-17 2002-05-31 Merck & Co Inc Metodo para a prevencao de zoster ou alivio de neuralgia pos-herpetica relacionada com varicela
KR100310510B1 (ko) 1993-03-23 2002-07-04 장 스테판느 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
ES2229264T5 (es) * 1995-03-23 2009-12-17 Immunex Corporation Receptor il-17.
US6846489B1 (en) 1995-04-25 2005-01-25 Smithkline Beecham Biologicals S.A. Vaccines containing a saponin and a sterol
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
AU743114B2 (en) 1997-04-01 2002-01-17 Corixa Corporation Aqueous immunologic adjuvant compositions of monophosphoryl lipid A
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
EP1279401B1 (en) 1997-09-05 2008-01-09 GlaxoSmithKline Biologicals S.A. Oil in water emulsions containing saponins
GB9901254D0 (en) 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
IL155282A0 (en) * 2000-10-18 2003-11-23 Glaxosmithkline Biolog Sa Vaccines
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine

Similar Documents

Publication Publication Date Title
US20230390381A1 (en) Immunogenic combinations
HRP20170081T1 (hr) Cjepivo protiv virusa varicela zoster
JP2023116652A (ja) サポニンを含むリポソーム製剤および使用方法
JP2008530245A5 (enExample)
ES2924988T3 (es) Composiciones con nanoemulsiones para prevenir, inhibir o eliminar una enfermedad alérgica e inflamatoria
JP2024161488A (ja) Ｂ型肝炎免疫化レジメン及び組成物
WO2006060710A3 (en) Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents
BE1022008B1 (fr) Compositions immunogenes combinees
EP3488865A1 (en) Method for eliciting in infants an immune response against rsv and b. pertussis
US20240382583A1 (en) Hepatitis b immunisation regimen and compositions
Garcia et al. An updated review of ISCOMSTM and ISCOMATRIXTM vaccines
Kawai et al. Lipid nanoparticle with 1, 2-Di-O-octadecenyl-3-trimethylammonium-propane as a component lipid confers potent responses of Th1 cells and antibody against vaccine antigen
JP2015525794A (ja) 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
JP2010180253A (ja) 抗原または免疫原に対する免疫応答を仕立てる方法。
US9303070B2 (en) Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2004016281A1 (en) Intradermal influenza vaccine compositions containing an adp-ribosylating factor
AR053661A1 (es) Peptido para entregar vacunas via mucosas
Morelli et al. ISCOMATRIX adjuvant in the development of prophylactic and therapeutic vaccines
TH81397A (th) วัคซีน
HK40060960A (en) Immunogenic combinations